Suven gets US court's approval to buy assets of Rising Pharmaceuticals

• Suven Life Sciences said it has received approval from a US bankruptcy court to buy assets of Rising Pharmaceuticals through its joint venture partner Shore Suven Pharma, reported Business Standard.

• The company has completed a "stalking horse agreement" as mandated by the bankruptcy court to buy the assets of Rising, Suven stated in a regulatory filing.

• The transaction is expected to close on April 19, according to the news source.

• "Leveraging Rising's extensive product portfolio and vertically integrating with Suven's world class [active pharmaceutical ingredients] and finished dose manufacturing capabilities will enable us to better serve US customers," said Shore Suven Pharma CEO Vimal Kavuru.

Register as Visitor to CPhI China 2019!

-----------------------------------------------------------------------
Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.